Metastatic cellular fibrous histiocytoma
Dermatologica Sinica, 2016 Fibrous histiocytoma is a common benign cutaneous tumor. Although most cases of fibrous histiocytoma pursue an indolent course, rare cases have been reported that show aggressive courses with metastases and fatality despite a benign pathology.
Yi-Teng Tseng +2 more
doaj +2 more sources
Capecitabine as second-line treatment for metastatic cholangiocarcinoma: A report of two cases [PDF]
, 2002 Background: The management of recurrent, metastatic cholangiocarcinoma still remains a problem since this tumor entity is classified as chemotherapy-resistant.
Schalhorn, A. +2 more
core +1 more source
Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer [PDF]
, 2010 Objectives: Bevacizumab is a monoclonal antibody that directly inhibits vascular endothelial growth factor, a key regulator of angiogenesis. Bevacizumab significantly improves progression-free and/or overall survival in metastatic colorectal cancer in ...
Volker Heinemann +3 more
core +1 more source
Metastatic Paraganglioma [PDF]
Seminars in Oncology, 2010 Paragangliomas (PGLs) are chromaffin cell tumors arising from ganglia; when arising in the adrenal gland they are called pheochromocytomas. In recent years the opinion that metastatic disease is rare in PGL had to be revised, particularly in patients presenting with extra-adrenal PGL, with PGLs exceeding 5 cm in diameter, and/or those carrying an SDHB ...
Stephanie M J, Fliedner +2 more
openaire +2 more sources
Biopsy confirmation of metastatic sites in breast cancer patients:clinical impact and future perspectives [PDF]
, 2014 Determination of hormone receptor (estrogen receptor and progesterone receptor) and human epidermal growth factor receptor 2 status in the primary tumor is clinically relevant to define breast cancer subtypes, clinical outcome, and the choice of therapy.
Carmen Criscitiello +38 more
core +2 more sources
Re-evaluation of HER2 status in metastatic breast cancer and tumor-marker guided therapy with vinorelbine and trastuzumab [PDF]
, 2005 Background: HER2 is overexpressed in 20 - 30% of breast cancers. Compared to chemotherapy alone, chemotherapy with trastuzumab improves clinical outcome in patients with HER2- positive metastatic breast cancer ( MBC). In general, HER2 status in a primary
Lässig, D. +3 more
core +1 more source
Quantifying metastatic inefficiency:rare genotypes versus rare dynamics [PDF]
, 2014 We introduce and solve a 'null model' of stochastic metastatic colonization. The model is described by a single parameter ?: the ratio of the rate of cell division to the rate of cell death for a disseminated tumour cell in a given secondary tissue ...
Newman, Timothy J., Cisneros, Luis H.
core +1 more source
Metastatic urothelial carcinoma
Anais Brasileiros de Dermatologia, 2021 A 61-year-old-man of the South of Spain presented at the Dermatology Department at Hospital Regional Universitario de Malaga with multiple painful erythemato-violaceous nodules on the chin, on the trunk, and the scalp (Fig. 1). The patient had been diagnosed with muscle-invasive micropapillary bladder cancer one year before and received treatment with ...
Elisabeth Gómez-Moyano +3 more
openaire +5 more sources
High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer [PDF]
, 2005 Background: Docetaxel is one of the most effective antitumor agents currently available for the treatment of metastatic breast cancer (MBC). This phase II multicenter study prospectively analyzed the efficacy and toxicity of docetaxel given on a weekly ...
Abenhardt, Wolfgang +29 more
core +1 more source
Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer [PDF]
, 2007 Background: Patients with metastatic breast cancer (MBC) are increasingly exposed to anthracyclines and taxanes either during treatment of primary breast cancer or during initial therapy of metastatic disease.
Vehling-Kaiser, U. +13 more
core +1 more source